1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SMAD4 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA CRTC1 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA ZNF124 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA BRD1 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA KIF5C CTRPv2 pan-cancer AAC 0.21 1e-07
mRNA C18orf32 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA SCAMP3 CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA GPATCH4 CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA DAND5 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA ZNF708 CTRPv2 pan-cancer AAC 0.2 1e-07
Download CSV